https://soleno.life/
Soleno, a Neurocrine Biosciences company – Development and commercialization of novel therapeutics...
https://www.prnewswire.com/news-releases/parkinson--movement-disorder-pmd-alliance-and-neurocrine-biosciences-announce-new-survey-results-revealing-the-significant-impact-off-time-has-on-people-with-parkinsons-disease-and-their-care-partners-301621508.html
Parkinson & Movement Disorder (PMD) Alliance and Neurocrine Biosciences Announce New Survey Results...
movement disorderpmd alliance
https://www.benzinga.com/insights/analyst-ratings/25/05/45218855/what-19-analyst-ratings-have-to-say-about-neurocrine-biosciences
What 19 Analyst Ratings Have To Say About Neurocrine Biosciences - Neurocrine Biosciences...
have to sayanalyst ratingsneurocrinebiosciences
https://www.neurocrineaccesssupport.com/
Neurocrine Access Support for CRENESSITY and INGREZZA
Discover Neurocrine Access Support, a comprehensive program for patients, caregivers, and healthcare professionals for treatment with CRENESSITY and INGREZZA.
access supportneurocrine
https://www.fool.com/investing/2018/09/30/heres-what-could-cause-neurocrine-biosciences-shar.aspx
Here's What Could Cause Neurocrine Biosciences Shares to Skyrocket | The Motley Fool
Sep 30, 2018 - This fast-growing biotech is on track for significant earnings growth.
https://www.fool.com/investing/2025/03/26/neurocrine-biosciences-a-smart-biotech-bet-with-bl/
Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential | The Motley Fool
Jul 3, 2025 - Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential
https://www.fool.com/earnings/call-transcripts/2020/05/07/neurocrine-biosciences-inc-nbix-q1-2020-earnings-c.aspx
Neurocrine Biosciences Inc (NBIX) Q1 2020 Earnings Call Transcript | The Motley Fool
May 7, 2020 - NBIX earnings call for the period ending March 31, 2020.
earnings call transcript